The last couple of months have been a busy time for UK liquid biopsy company, Angle PLC. The firm may not be the biggest player in this broad and increasingly competitive area but it has made significant inroads as one of the leading runners in the circulating tumor cell capture field with its Parsortix system, which is currently being used by several cancer research institutes in the diagnosis and monitoring of various cancers.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?